4D pharma Announces Completion of Merger With Longevity Acquisition CorporationBusiness Wire • 03/22/21
Completion of Merger With Longevity Acquisition Corporation and Admission of American Depositary Shares to Trading on NASDAQBusiness Wire • 03/22/21
Longevity Acquisition Corporation Announces Results of Special Meeting of ShareholdersPRNewsWire • 03/18/21
4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management TeamBusiness Wire • 03/01/21
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Longevity Acquisition Corp. - LOACPRNewsWire • 02/27/21
4D Pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQBusiness Wire • 02/26/21
Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers InitiativePRNewsWire • 12/21/20
Longevity Acquisition Corporation Regains Compliance with Nasdaq Listing RequirementPRNewsWire • 12/11/20
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Longevity Acquisition Corporation MergerGlobeNewsWire • 12/02/20
4D pharma plc Files SEC Forms in Process to Gain NASDAQ Listing Following Merger with Longevity, a Special Purpose Acquisition Company (SPAC)Business Wire • 11/27/20
Longevity Acquisition Corporation Announces Extension of Deadline to Complete a Business CombinationPRNewsWire • 11/20/20
Longevity Acquisition Corporation Announces Increased Cash Contribution for the ExtensionPRNewsWire • 11/17/20